Anticoagulation Management and Outcomes in Patients With Covid-19 With Propensity Score Matching: A Multicenter Retrospective Cohort Study.
Jasmeet KaurJennifer deLongpreTracy KoehlerHeather LaclairMonica BowenJustin KhineNadia KhosrodadNihar JenaPriyadarshini DixitSumeet YadavSwathi M MogullaRob CoakleyAnupam SuleGeetha KrishnamoorthyPublished in: American journal of therapeutics (2021)
We found no difference in mortality in patients with Covid-19 without clinically evident venous thromboembolism, atrial fibrillation, and myocardial infarction who received therapeutic versus prophylactic doses of anticoagulation.
Keyphrases
- venous thromboembolism
- atrial fibrillation
- direct oral anticoagulants
- heart failure
- oral anticoagulants
- catheter ablation
- left atrial
- cardiovascular events
- left atrial appendage
- left ventricular
- cross sectional
- risk factors
- percutaneous coronary intervention
- coronary artery disease
- cardiovascular disease
- type diabetes
- adipose tissue
- glycemic control
- acute coronary syndrome